Randomised high- and low-dose heparin prophylaxis in patients undergoing thoracotomy for benign and malignant disease: effect on thrombo-elastography

被引:26
作者
Attaran, Saina [1 ]
Somov, Pavlo [1 ]
Awad, Wael I. [1 ]
机构
[1] London Chest Hosp, Dept Cardiothorac Surg, Barts & London NHS Trust, London E2 9JX, England
关键词
Lung cancer; Hypercoagulability; Thromboprophylaxis; Thrombo-embolism; MOLECULAR-WEIGHT HEPARIN; UNFRACTIONATED HEPARIN; VENOUS THROMBOEMBOLISM; THROMBOELASTOGRAPHY; PREVENTION;
D O I
10.1016/j.ejcts.2009.12.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Both cancer patients and patients undergoing surgery are thought to be at an increased risk of thrombo-embolic events. Consequently, low-molecular-weight heparin (LMWH) is administered to all such patients perioperatively. There is a lack of consensus in guidelines regarding the timing of administration and the dosage of thromboprophylactic agents. Studies have shown that thrombo-elastography (TEG) is a useful test in assessing global haemostatic function, and has been validated in monitoring the dosage of LMWH. In this study, we assess the coagulation status of patients undergoing thoracic surgery with TEG, and the effectiveness of administered LMWH for thromboprophylaxis. Methods: Thirty patients with primary lung cancer (LC) and 30 with benign lung disease (BL) were studied prospectively. Patients were randomised to receive subcutaneous LMWH 40 mg once or twice per day perioperatively. Their coagulation status was monitored with TEG preoperatively and postoperatively for 3 consecutive days. Results: Preoperative TEG parameters (k time, alpha angle and maximum amplitude (MA)) were within the normal range in both the LC and BL groups. Preoperative r time was prolonged in both the groups, but with no significant difference between the two groups ( p > 0.05). Postoperatively, r time was prolonged in some patients receiving LMWH twice daily, suggesting a possible adequate thromboprophylaxis in these patients only. Conclusion: This study demonstrates that the majority of patients with LC are not hypercoagulable. We also showed that LMWH once or twice a day might not provide sufficient thromboprophylaxis. We advocate screening for patients demonstrating hypercoagulable states and ensuring adequate thromboprophylaxis in this group of patients with careful monitoring. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1384 / 1390
页数:7
相关论文
共 24 条
[1]  
[Anonymous], NICE CLIN GUID
[2]   Venous thromboembolism and cancer [J].
Baron, JA ;
Gridley, G ;
Weiderpass, E ;
Nyrén, O ;
Linet, M .
LANCET, 1998, 351 (9109) :1077-1080
[3]   Malignancies, prothrombotic mutations, and the risk of venous thrombosis [J].
Blom, JW ;
Doggen, CJM ;
Osanto, S ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :715-722
[4]   Utilisation and safety of low molecular weight heparins -: Prospective observational study in medical inpatients [J].
Cestac, P ;
Bagheri, H ;
Lapeyre-Mestre, M ;
Sié, P ;
Fouladi, A ;
Maupas, E ;
Léger, P ;
Fontan, B ;
Massip, P ;
Montastruc, JL .
DRUG SAFETY, 2003, 26 (03) :197-207
[5]   Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis [J].
Donahue, SM ;
Otto, CM .
JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE, 2005, 15 (01) :9-16
[6]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S
[7]   Prevention of venous thromboembolism [J].
Geerts, William H. ;
Bergqvist, David ;
Pineo, Graham F. ;
Heit, John A. ;
Samama, Charles M. ;
Lassen, Michael R. ;
Colwell, Clifford W. .
CHEST, 2008, 133 (06) :381S-453S
[8]  
Gottlieb A, 1999, ANESTH ANALG, V88
[9]   BLUTGERINNUNGSSTUDIEN MIT DER THROMBELASTOGRAPHIE, EINEM NEUEN UNTERSUCHUNGSVERFAHREN [J].
HARTERT, H .
KLINISCHE WOCHENSCHRIFT, 1948, 26 (37-3) :577-583
[10]   Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: A comparison with anti-Xa concentrations [J].
Klein, SM ;
Slaughter, TF ;
Vail, PT ;
Ginsberg, B ;
El-Moalem, HE ;
Alexander, R ;
D'Ercole, F ;
Greengrass, RA ;
Perumal, TTM ;
Welsby, I ;
Gan, TJ .
ANESTHESIA AND ANALGESIA, 2000, 91 (05) :1091-1095